Quantcast

Prehypertension is real and can be associated with target organ damage.

Research paper by Barry J BJ Materson, Manuel M Garcia-Estrada, Stephane B SB Degraff, Richard A RA Preston

Indexed on: 03 Oct '17Published on: 03 Oct '17Published in: Journal of the American Society of Hypertension



Abstract

Prehypertension (systolic blood pressure 120-139 or diastolic blood pressure 80-89 mm Hg) confers a risk of progression to hypertension, impairment of cognitive function, increased left ventricular mass, risk of end-stage renal disease, and an association with arteriosclerosis. Recent studies provide data that could support the rationale for treating prehypertensives subjects with antihypertensive medications in addition to lifestyle modification, especially if they have concomitant cardiovascular risk factors.